trial · primary record
Biospecimen Collection
Borderline Resectable Pancreatic Adenocarcinoma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 56 |
| Primary completion | 2027-03-02 |
| Primary endpoint | Incidence of adverse events (BPRC Cohort) |
| Registry ID | NCT05688215 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:23.553Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05688215
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Biospecimen Collection · compound